. Author manuscript; available in PMC: 2017 Mar 9.

Published in final edited form as: Bone Marrow Transplant. 2015 Jul 13;50(11):1432–1437. doi: 10.1038/bmt.2015.162

Table 3.

1 year overall survival and treatment-related mortality by multivariate analysis in patients with HC

	OS			TRM
Parameter	Class	Hazard Ratio CI 95%	P-value	Hazard Ratio CI 95%	P-value
HC Group	Control	1.00	0.14	1.00
	Grade I-II	0.76 (0.52-1.11)		0.91 (0.59-1.42)	0.69
	Grade III-IV	1.20 (0.90-1.61)		1.52 (1.10-2.10)	0.01
Graft source	M BM/PBSC	1.00	<0.01	1.00
	MM BM/PBSC	2.60 (1.90-3.55)		2.28 (1.53-3.41)	<0.01
	M UCB	1.14 (0.77-1.68)		1.34 (0.85-2.12)	0.21
	MM UCB	1.53 (1.25-1.89)		1.43 (1.10-1.87)	0.01

Covariates tested in UVA were: ATG, sex, age, disease risk, conditioning regimen intensity

Abbreviations:BM, bone marrow; CMV, cytomegalovirus; HC, hemorrhagic cystitis; M, matched; MM, mismatched; PBSC, peripheral blood stem cell; UCB, umbilical cord blood.